These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23597193)

  • 21. Advances in translational pharmacological investigations in identifying and validating molecular targets of natural product anticancer agents.
    Yu J; Nag SA; Zhang R
    Curr Cancer Drug Targets; 2013 Jun; 13(5):596-609. PubMed ID: 23597194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs and anticancer drugs.
    Xing Z; Li D; Yang L; Xi Y; Su X
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):233-9. PubMed ID: 24492536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
    Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
    Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.
    Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S
    Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.
    Huang J; Zhang SY; Gao YM; Liu YF; Liu YB; Zhao ZG; Yang K
    Cell Prolif; 2014 Aug; 47(4):277-86. PubMed ID: 24909356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
    Goblirsch M; Richtig G; Slaby O; Berindan-Neagoe I; Gerger A; Pichler M
    Pharmacogenomics; 2017 Jul; 18(10):1027-1038. PubMed ID: 28639472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MicroRNA in Various Aspects of Cancer Development].
    Nambara S; Mimori K
    Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
    Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
    Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrantly expressed microRNAs in the context of bladder tumorigenesis.
    Lee JY; Ryu DS; Kim WJ; Kim SJ
    Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S52-9. PubMed ID: 27326408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNAs in breast cancer development and treatment.
    Serpico D; Molino L; Di Cosimo S
    Cancer Treat Rev; 2014 Jun; 40(5):595-604. PubMed ID: 24286642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulating miRNA by natural agents as a new strategy for cancer treatment.
    Sethi S; Li Y; Sarkar FH
    Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
    Qin C; Huang RY; Wang ZX
    Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
    Chen E; Xu X; Liu R; Liu T
    Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.